RAPP
Rapport Therapeutics, Inc. Common Stock
stockNASDAQ
Market OpenOct 12, 2026 12:02:58 PM EDT
30.57USD-0.261%(-0.08)25,760
26.27Bid35.15Ask8.88SpreadRAPP News
Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock · 
Investing.com
Notable Thursday Option Activity: SGHC, RAPP, BE · 
BNK Invest
Rapport Therapeutics CEO Ceesay sells $86,565 in company stock · Investing.com
Why is Rapport Therapeutics stock sliding today? · Investing.com
Rapport Therapeutics at TD Cowen summit: bipolar data loom · Investing.com
The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data · 
Investor's Business Daily
BTIG raises Rapport Therapeutics price target to $75 on RAP-219 · Investing.com